ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 438

Methyl Supplementation of Rheumatoid Arthritis Synovial Fibroblasts Regulates the Expression of Transcription Factors and Matrix Metalloproteinases

Edvardas Bagdonas1, Emmanuel Karouzakis2, Astrid Jungel2, Caroline Ospelt1, Renate E. Gay1, Steffen Gay1, Beat A. Michel1 and Michel Neidhart1, 1Center of Experimental Rheumatology, University Hospital Zurich, Zurich, Switzerland, 2Center of Experimental Rheumatology, University Hospital Zurich and Zurich Center of Integrative Human Physiology (ZIHP), Zurich, Switzerland

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Animal models, Epigenetics, nutrition, rheumatoid arthritis (RA) and synovial cells, synovial fluid

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Rheumatoid Arthritis - Human Etiology and Pathogenisis

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Previously we reported that methyl supplementation can reverse the global hypomethylation of rheumatoid arthritis synovial fibroblasts (RASF) and attenuate their aggressive behaviour. Now we analysed the molecular changes occurring in matrix metalloproteinases (MMPs) and transcription factors after treatment with methyl supplementation.

Methods:

RASF (n=6 patients) were cultured in DMEM/F12 + 10% FCS as a control and in medium supplemented with 10-fold excess amount of folic acid (70 µM), vitamin B12 (6 µM) and L-methionine (1,1 mM) (high supplementation – HS) for 10 days. After the treatment, cells were counted to determine doubling time, their RNA isolated and supernatants were tested using MMPs ELISA assays. The gene expression of MMPs and transcription factors was evaluated by real time-PCR and gene expression array (QIAGEN RT2 Profiler PCR Human Transcription Factors Array), respectively. The untreated and treated RASF were implanted together with normal human cartilage into SCID mice. The cartilage sample slides were scored by three independent investigators.

Results:

After 10 days of culturing in HS medium, the expression of MMP1 gene was significantly down regulated (p = 0.034) while changes in the mRNA level of MMP3 were not significant (p = 0.56). There was also a significant reduction in the level of MMP1 protein in RASF grown in HS medium (p = 0.027) and no significant reduction of MMP3 protein level (p = 0.49). The effect of HS on the state of DNA methylation and gene expression is dependent on cell proliferation. Indeed, MMP1 expression strongly correlated with the cell population doubling time – r = 0.9455, p = 0.0044. The expression of 6 out of 84 analyzed genes was significantly changed by methyl supplementation. ELK1, HDAC1, HSF1 were up regulated while JUN, NFATC3 and SMAD9 were down regulated (p < 0.05). Most interestingly, HS treated RASF showed reduced invasion and perichondrocytic degradation in the SCID mouse invasion model in vivo(invasion score: control 2.25±0.27; HS 1.26±0.26, p<0.03, n=5; perichondrocytic score: control 1.91±0.18; HS 1.17±0.23, p<0.01, n=5).

Conclusion:

Methyl supplementation reduced the expression of MMP1, significantly altered expression pattern of 6 transcription factors and inhibited the invasive properties of RASF in vivo. Therefore, this supplementation might be used as a novel therapeutic approach to inhibit joint destruction in rheumatoid arthritis.


Disclosure:

E. Bagdonas,

Sciex-Fellowship,

2;

E. Karouzakis,

IAR, IMI-BTCure,Novartis Stiftung,

2;

A. Jungel,

IAR,Masterswitch-FP7,IMI-BTCure,

2;

C. Ospelt,

her institution,

3;

R. E. Gay,

Masterswitch-FP7 and her institution,

2;

S. Gay,

IAR and his institution,

2;

B. A. Michel,

his institution,

3;

M. Neidhart,

his institution,

3.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/methyl-supplementation-of-rheumatoid-arthritis-synovial-fibroblasts-regulates-the-expression-of-transcription-factors-and-matrix-metalloproteinases/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology